Failure of B Cell Tolerance in CVID

Area of Science:

• Immunology
• Autoimmunity
• B cell biology

Background:

• Common variable immunodeficiency (CVID) is characterized by impaired B cell function and antibody production.
• Autoimmune features are frequent in CVID, but their mechanisms remain unclear.
• Shared features with systemic lupus erythematosus (SLE) suggest overlapping autoimmune pathways, particularly B cell tolerance defects.

Purpose of the Study:

• To comprehensively investigate 9G4+ B cells across B cell development in CVID patients.
• To compare 9G4+ B cell populations in CVID patients with and without autoimmune features.
• To explore the role of specific autoreactive B cell subsets in CVID-associated autoimmunity.

Main Methods:

• Flow cytometry was used to analyze B cell subpopulations in detail.
• 9G4+ B cells were examined throughout B cell development stages.
• Autoreactive B cell subsets, including activated naïve (aNAV) and double negative 2 (DN2) B cells, were assessed.

Main Results:

• CVID patients with autoimmune features exhibited significant expansion of 9G4+ B cells in both naïve and memory populations.
• An expanded 9G4+ DN2 B cell population was identified in CVID patients.
• These findings indicate defects in both central and peripheral B cell tolerance are linked to autoimmunity in CVID.

Conclusions:

• The study identifies an expansion of autoreactive 9G4+ B cells, particularly the 9G4+ DN2 subset, in CVID patients with autoimmune features.
• These findings highlight the role of B cell tolerance defects in CVID autoimmunity.
• The autoreactive DN2 B cell population may be a key factor in the development of autoimmunity in CVID.